Picture of SyntheticMR AB (publ) logo

SYNT SyntheticMR AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for SyntheticMR AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.8659.997.2214.1-18.3
Depreciation
Non-Cash Items-0.326-2.441.5-0.987
Other Non-Cash Items
Changes in Working Capital-13.8-9.92-25.2-28.810.7
Change in Accounts Receivable
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-8.934.35-15.2-6.96-1.71
Capital Expenditures-5.55-5.11-10.5-9.71-8.72
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.1110.0010.056
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-5.55-5.22-10.5-9.71-8.66
Financing Cash Flow Items-5.350-0.268
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-7.04-0.95753.7-1.0139.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-21.7-1.4528.9-19.229.7